These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39213062)

  • 1. Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome.
    Saternos H; Hamlett ED; Guzman S; Head E; Granholm AC; Ledreux A
    J Alzheimers Dis; 2024; 101(2):541-561. PubMed ID: 39213062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
    Kasri A; Camporesi E; Gkanatsiou E; Boluda S; Brinkmalm G; Stimmer L; Ge J; Hanrieder J; Villain N; Duyckaerts C; Vermeiren Y; Pape SE; Nicolas G; Laquerrière A; De Deyn PP; Wallon D; Blennow K; Strydom A; Zetterberg H; Potier MC
    Acta Neuropathol; 2024 Jul; 148(1):8. PubMed ID: 39026031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.
    Chalermpalanupap T; Weinshenker D; Rorabaugh JM
    Neural Plast; 2017; 2017():7829507. PubMed ID: 29038736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.
    Drummond E; Kavanagh T; Pires G; Marta-Ariza M; Kanshin E; Nayak S; Faustin A; Berdah V; Ueberheide B; Wisniewski T
    Acta Neuropathol Commun; 2022 Apr; 10(1):53. PubMed ID: 35418158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
    Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
    Pamphlett R; Kum Jew S
    J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
    Lemoine L; Ledreux A; Mufson EJ; Perez SE; Simic G; Doran E; Lott I; Carroll S; Bharani K; Thomas S; Gilmore A; Hamlett ED; Nordberg A; Granholm AC
    Mol Neurodegener; 2020 Nov; 15(1):68. PubMed ID: 33222700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer's disease pathology in Down syndrome.
    Maxwell AM; Yuan P; Rivera BM; Schaaf W; Mladinov M; Prasher VP; Robinson AC; DeGrado WF; Condello C
    Acta Neuropathol Commun; 2021 Dec; 9(1):201. PubMed ID: 34961556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
    Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
    PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
    Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
    Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
    Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P
    Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
    Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
    Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease.
    Ehrenberg AJ; Nguy AK; Theofilas P; Dunlop S; Suemoto CK; Di Lorenzo Alho AT; Leite RP; Diehl Rodriguez R; Mejia MB; Rüb U; Farfel JM; de Lucena Ferretti-Rebustini RE; Nascimento CF; Nitrini R; Pasquallucci CA; Jacob-Filho W; Miller B; Seeley WW; Heinsen H; Grinberg LT
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):393-408. PubMed ID: 28117917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
    Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
    Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.
    Perluigi M; Pupo G; Tramutola A; Cini C; Coccia R; Barone E; Head E; Butterfield DA; Di Domenico F
    Biochim Biophys Acta; 2014 Jul; 1842(7):1144-53. PubMed ID: 24735980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.
    Sakakibara Y; Hirota Y; Ibaraki K; Takei K; Chikamatsu S; Tsubokawa Y; Saito T; Saido TC; Sekiya M; Iijima KM
    J Alzheimers Dis; 2021; 82(4):1513-1530. PubMed ID: 34180416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological and neurochemical correlates of locus coeruleus functional network activity.
    Parent JH; Cassady K; Jagust WJ; Berry AS
    Biol Psychol; 2024 Oct; 192():108847. PubMed ID: 39038634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer's disease.
    Giorgi FS; Saccaro LF; Galgani A; Busceti CL; Biagioni F; Frati A; Fornai F
    Brain Res Bull; 2019 Nov; 153():47-58. PubMed ID: 31419539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
    Beckers E; Riphagen JM; Van Egroo M; Bennett DA; Jacobs HIL
    J Alzheimers Dis; 2024; 99(1):105-111. PubMed ID: 38607758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.